FDA Inspection
Similasan AGSimilasan AG – FDA Inspection, Apr 27, 2026
Record Details
This FDA Inspection record concerns Similasan AG, with an inspection on April 27, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 001769e1-a17a-4bce-b22f-63417f904cc9
Inspection Facts
- Inspection number
- 1313406
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.160(b)(1)Determination of conformance
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Similasan AG
5| Date | Classification | Office | Project area |
|---|---|---|---|
| April 4, 2023 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 18, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 23, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 13, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 27, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Similasan AG
- FDA Inspection 1204144 - 2023-04-04
- FDA Inspection 1028938 - 2017-09-18
- FDA Inspection 937801 - 2015-07-23
- FDA Inspection 851899 - 2013-09-13
- FDA Inspection 727380 - 2011-05-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.